Claudio Cerchione: EHA 2026 Highlights Ongoing Therapeutic Revolution in Multiple Myeloma
Claudio Cerchione/X

Claudio Cerchione: EHA 2026 Highlights Ongoing Therapeutic Revolution in Multiple Myeloma

Claudio Cerchione, Medical Director Researcher of Hematology Unit – IRST IRCCS Meldola, shared a post on X:

“Dear friends, Today two talks at European Hematology Association in Stockholm, incredible acknowledgement: we focused on the therapeutic revolution in Multiple Myeloma, which continue without stopping!”

Claudio Cerchione

Other articles about Multiple Myeloma on OncoDaily.